The Access to Medicines: The Weak Link of the Exemption of Healthcare Payment Policy for the Elderly in Senegal
Science Journal of Public Health
Volume 5, Issue 4, July 2017, Pages: 307-312
Received: Apr. 5, 2017; Accepted: Apr. 21, 2017; Published: Jun. 15, 2017
Views 1975      Downloads 52
Authors
Ka Ousseynou, Faculty of Health and Sustainable Development, Alioune Diop University, Bambey, Senegal; Centre of Gerontology Center of Ouakam, Dakar, Senegal
Sow Papa Gallo, Faculty of Health and Sustainable Development, Alioune Diop University, Bambey, Senegal
Bop Martial Coly, Faculty of Health and Sustainable Development, Alioune Diop University, Bambey, Senegal
Mbaye El Hadji, Simone de Beauvoir Institute of Concordia University, Montréal, Canada
Tall Alioune Badara, Faculty of Health and Sustainable Development, Alioune Diop University, Bambey, Senegal
Touré Moustapha, Centre of Gerontology Center of Ouakam, Dakar, Senegal
Article Tools
Follow on us
Abstract
The institutionalization of the Plan Sesame in Senegal or free access to healthcare for the elderly translates a real political will of decision-makers to answer the sanitary concerns of this category of vulnerable population. The objective of this study is to estimate the effectiveness of the free access to the Plan Sesame and to collect the appreciations of the recipients of the Plan. This study is based on a data connection of qualitative data in 2010 with the elderly and decision-makers and on a transverse quantitative and qualitative study in 2011 made to the only geriatric hospital of the country. The elderly are particularly affected by chronic pathologies and most drugs of which they need are not dealt by the Plan. They must buy them in private pharmacies. The not provision of these drugs known as of speciality favors the recourse to the illicit market of drugs with traditional medicine and even with the therapeutic abandonment. Moreover it worsened the social inequalities of health within the recipients of this Plan.
Keywords
Health Policy, Free Access to Healthcare, Drugs, Elderly, Senegal
To cite this article
Ka Ousseynou, Sow Papa Gallo, Bop Martial Coly, Mbaye El Hadji, Tall Alioune Badara, Touré Moustapha, The Access to Medicines: The Weak Link of the Exemption of Healthcare Payment Policy for the Elderly in Senegal, Science Journal of Public Health. Vol. 5, No. 4, 2017, pp. 307-312. doi: 10.11648/j.sjph.20170504.15
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
National Agency of the Statistics and Demography (2002) general census of the population and the habitat, Dakar.
[2]
Ka O (2002) Planning of the athermanous chronic diseases), Mémoire ISED Dakar.
[3]
Institut IDEA International (2008): study on the living conditions of the over-sixties years old person in Senegal, Rapport, Dakar.
[4]
Berthé Abdramane et Al (2013) Elderly people in sub-Saharan Africa: a vulnerable population, toof ten neglected in the public policies, Public health: 25; 367-71.
[5]
Ministry of Health and prevention, Direction of Health, Office of the Health of the Elderly people (2008): Project of implementation of the system of solidarity “Sésame” in favour of the 60 year old elderly people and more in Senegal, Dakar.
[6]
Berthé A, Berthé-Sanou L, Konaté B, Hien H, Tou F, Somda S, et al. (2013) Uncovered needs of the elderly people in functional incapacities in Bobo-Dioulasso (Burkina Faso). Rev Epidemol Public Health, 61 (6): 531-37.
[7]
Mbaye EM, Ridde V, Ka O (2013) Good intentions are not enough: analysis of a health policy for the elderly people in Senegal: Public Health: 25 (1): 107-12.
[8]
Touré M (2012): Assessment of the cost of the care of the elderly person in the center of gerontology and geriatrics of Ouakam, Doctorate Thesis / Dakar n°21.
[9]
Moynihan R (2006): Inventions of diseases in order to sell drugs, le Monde Diplomatique, 626.
[10]
Manga JS (2004) Approach on the sexuality and the erectile dysfunction of the retired subject) n°60, Dakar.
[11]
Timera D (2004): Epidemiologic, clinical and therapeutic aspects of the High blood pressure, Medicine Thesis, Dakar n°45.
[12]
Kereouedan D (2011) International health. Challenges of health in the South, Presses de Sciences Po “Hors-collection”, Paris.
[13]
Ministry of Health, Direction of Pharmacy and the laboratories national pharmaceutical Policy (2006), Dakar.
[14]
Muller P (2003): Public Policies, What do we know?
[15]
Olivier de Sardan J-P, et Ridde V (2012): The exemption of payment of the care in Burkina Faso, Mali and Niger: Contradictions of the public policies, Contemporary Africa; 3 (243): 11-32.
[16]
Bayart JF: the State in Africa (1989) the belly policy, Fayard, Paris.
[17]
Eboko F (2005) Public Policy and AIDS in Africa: Notebook of African Studies: 178: 2-27.
[18]
Ferchichi S, Antoine V (2005) The good use of the drugs by the elderly person: Rev Med Interne 25: 582-90.
[19]
Helfter C (2007) Pathologies of senescence: social information; 2 (138): 117-18.
[20]
WHO, Ministry of the Health of Senegal: Evaluation of the pharmaceutical sector in Senegal: Report of investigation 2003. http://apps.who.int/medicinedocs/documents/s16430f/s16430f.pdf
[21]
Bernier Nf. Mallon I (2009) Is getting older a problem?, Lien so et po, RIAC; 62: 180 p.
[22]
Mc Coy, D, Hall JA, Ridge M A (2012) Systematic review of the literature for Evidence on Health Facility committies in Low and Middle-Income Countries, Health Policy Planning; 27 (6): 449-66.
[23]
Velasquez, G (1999): essential drugs and globalization, conference of the AIDE “Pharmaceutical Brevets, innovations and public health” Toulouse; 28-30 January.
[24]
Léveque F, Ménière Y (2003) Economy of the intellectual property: La Découverte, Repères, Paris.
[25]
Castro DR, le Gall J-M, Jablonski O (2009) Improving Health of the HIV positive people with the VIH: SERONET, a new tool of the community approach, Public health: 21: 129-39.
[26]
Ridde V, Blanchet K: Debates and challenges around free care in Africa " back to the future "? Cahiers of studies and research Free, 2009; 19 (2): 101-6.
[27]
Henrard JC (2002) The French system of assistance and care for the elderly: Health, society, solidarity: 2: 72-81.
[28]
Ndiaye O, Dieme EJG (2007): Evaluation of the initiatives of subsidies and social fund, Rapport d’évaluation, Dakar.
[29]
Ridde V, Queille L, Kafando Y (2009): Capitalizations of public policies of exemption of the payment of the care in Africa: “return towards the future”? Cahiers of studies and research Free; 19 (2): 101-6.
[30]
Seck A, Lazure G, Diane M (2012): Experiments of ageing lived by Senegalese women of 60 years old and more, alive in the community. Qualitative Research; 31 (1): 1 - 23.
[31]
Ouattara A (2009) Purchase of drugs of the informal market in Africa: Comprehension of an “irrational” behavior), Market Management; 9 (1): 59-73.
[32]
Pinel J (2005) Generic, counterfeit, quality: Which drugs for the countries in the process of development? Les tribunes de la Santé; 1 (6): 49 – 55.
[33]
Fassin D (1985) From illegal work to the unofficial, The networks of illicit sale of medicine in Senegal: Notebook of African Studies: 25 (98): 161-77.
[34]
Velasquez G (1999): Essential Drugs and Globalization Symposium HELP " Pharmaceutical Patents, innovation and public health," Toulouse.
[35]
Gurwitz JH, Field TS, Harrold LR, et al (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting: JAMA 289: 1107-16.
[36]
Van L, W, Brouwere V (2000): Health status and health of the State in Sub-Saharan Africa), Contemporary Africa; 195: 175-190.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186